Co-expression prognostic-related genes signature base on propofol and sevoflurane anesthesia predict prognosis and immunotherapy response in glioblastoma-Reference-Cited by-同舟云学术

Co-expression prognostic-related genes signature base on propofol and sevoflurane anesthesia predict prognosis and immunotherapy response in glioblastoma

Published:2023-03 Issue:1 Volume:55 Page:778-792
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Hou Zhiqi¹,Luo Dexing¹,Luo Huanhuan¹,Hui Qiang¹,Xu Yongqing²,Lin Xiaofeng¹,Xu Zhibin³

Affiliation:

1. Hui Zhou Central People’s Hospital, HuiZhou, Guangdong, China

2. Department of Anesthesiology, Hui Dong County People’s Hospital, HuiZhou, Guangdong, China

3. Department of Basic Medical Sciences, Aspire (Hong Kong) Medical Research Center, Hong Kong, China

Funder

Huizhou Medical and Health Science and Technology Plan Project

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2023.2171109

Reference43 articles.

1. Glioblastoma: clinical presentation, diagnosis, and management

2. Brain malignancies: Glioblastoma and brain metastases

3. Molecular Mechanisms of Treatment Resistance in Glioblastoma

4. Advances in the management of glioblastoma

5. Sevoflurane promotes migration, invasion, and colony-forming ability of human glioblastoma cells possibly via increasing the expression of cell surface protein 44

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Model and Immune Response of Clear Cell Renal Cell Carcinoma Based on Co-Expression Genes Signature;Clinical Genitourinary Cancer;2024-07

2. Impact of propofol versus sevoflurane anesthesia on molecular subtypes and immune checkpoints of glioma during surgery;Health Science Reports;2023-09

3. Risk factors for surgical compliance and impact on the survival of patients with glioma: a population-based propensity score-matched study;Journal of Cancer Research and Clinical Oncology;2023-08-17